Subspecialties

Four AI and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next

Thyroid eye disease may have met its match in teprotumumab

From a single cornea to a hundred cell therapy injections: is CorneaGen on course to end our dependence on donor tissue?

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Researchers shed light on how dscaml1 deficiency affects neural development and eye movements in zebrafish

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Electrical stimulation of neural responses can significantly improve outcomes for retinitis pigmentosa patients

This month’s image shows posterior staphyloma

Raising awareness and understanding of a largely misunderstood condition: the Charles Bonnet Syndrome

When even the world’s wealthiest economies struggle to fund gene therapies, we have a problem that demands disruptive solutions